Package 0115-1911-01

{"route": ["ORAL"], "spl_id": "b5f5cd6c-3874-4507-bbd4-72e8c5bfe17f", "openfda": {"unii": ["JEI07OOS8Y"], "rxcui": ["856605"], "spl_set_id": ["49f7d69a-820b-4c75-a31d-b2104c019c12"], "manufacturer_name": ["Amneal Pharmaceuticals of New York LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "100 TABLET, FILM COATED in 1 BOTTLE (0115-1911-01)", "package_ndc": "0115-1911-01", "marketing_start_date": "20211116"}, {"sample": false, "description": "500 TABLET, FILM COATED in 1 BOTTLE (0115-1911-02)", "package_ndc": "0115-1911-02", "marketing_start_date": "20211116"}], "brand_name": "Rimantadine Hydrochloride", "product_id": "0115-1911_b5f5cd6c-3874-4507-bbd4-72e8c5bfe17f", "dosage_form": "TABLET, FILM COATED", "pharm_class": ["Influenza A M2 Protein Inhibitor [EPC]", "M2 Protein Inhibitors [MoA]"], "product_ndc": "0115-1911", "generic_name": "Rimantadine Hydrochloride", "labeler_name": "Amneal Pharmaceuticals of New York LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Rimantadine Hydrochloride", "active_ingredients": [{"name": "RIMANTADINE HYDROCHLORIDE", "strength": "100 mg/1"}], "application_number": "ANDA076132", "marketing_category": "ANDA", "marketing_start_date": "20211116", "listing_expiration_date": "20261231"}